The science

Supplements fail
before they start.

Most compounds never reach the point of absorption. That is not a personalisation problem. It is a delivery problem.

The problem with pills

The stomach destroys most of what you swallow.

Gastric acid sits at a pH of 1.5 to 3.5. Most supplement compounds — fat-soluble vitamins, botanical extracts, amino acids — are partially or fully degraded before they reach the small intestine, the site where absorption actually occurs.

Compressed tablets and standard capsules dissolve indiscriminately. There is no mechanism to protect a compound through the stomach or to time its release for the intestinal region where it is most efficiently absorbed.

5–95%Bioavailability varies this much depending on compound and delivery format. A poorly delivered formula is not a formula. It is an expensive exercise in hope.

Microgranule technology

Pharmaceutical-grade delivery.

Each PARTICULAR formula is blended as spherical microgranules of 0.7–1.2mm, produced by pharmaceutical extrusion-spheronization — a process with a 30-year history in pharmaceutical medicine and a proven safety record across thousands of licensed drug formulations.

Each microgranule is individually coated to control exactly where in the digestive tract it dissolves. The coating material, its thickness, and its composition are calibrated per ingredient — not per formula.

Patented process. Peer-reviewed validation. GMP-certified facility. Not standard supplement manufacturing — pharmaceutical production technology, applied to personalised nutrition.

Microgranule cross-section showing active compound core, enteric coating layer, and protective polymer shell

Delivery in action

Three stages.
Nothing wasted.

From dry particle to intestinal absorption — the enteric coating protects each compound through the stomach's acid environment, then dissolves precisely at the point of highest absorption efficiency.

Ingredient selection

The form matters as much as the dose.

Four mechanisms.
One monthly blend.

Gastric protection

Enteric coating resists stomach acid. Active compounds reach the intestine intact.

Controlled release

Coating thickness sets the release rate. Each ingredient dissolves where and when it should.

Dose uniformity

Every microgranule holds the same concentration. 300mg specified means 300mg delivered.

Independent release

Compounds that compete for absorption in a capsule are separated. Each completes its own cycle.

Build my formulaEvery formula uses this delivery system.
PARTICULAR measuring scoop filled with personalised microgranules

How PARTICULAR compares

Not pills. Not powders. Not gummies.

PARTICULAR

Others

Protected through stomach acid

Destroyed or unprotected

Each ingredient released independently

Everything dissolves together

No sugar, fillers or binders

Additives typical

Full formula in one daily scoop

Multiple pills or sachets

Ingredients can't interfere with each other

Mineral competition at absorption

Scored against your biology

Same formula for everyone

Bioavailable forms of every ingredient

Cheapest available

Vegan & gluten-free

GMP certified

No capsules

One scoop, once a day

Quality & provenance

Every batch. Every ingredient. Verified.

Manufactured in a GMP-certified facility in Germany. Every ingredient handpicked from leading industry suppliers — the most researched forms, not generic fillers.

The microgranule process is protected by three independent patents covering the manufacturing method, coating application, and particle geometry. The technology is not replicated by the generic supplement industry.

Peer-reviewed validation in pharmaceutical journals — not nutritional supplement trade press — confirms delivery efficacy across multiple compound classes.

GMP Certified — Good Manufacturing Practice
Germany · UK
Particle size0.7–1.2mm spherical
ProcessExtrusion-spheronization
Coating typeEnteric / controlled-release
ManufacturingGMP-certified facility, Germany
Process patentsIT1270216B · US5460828A · US5296236A
Peer-reviewedVervaet & Remon, Int J Pharmaceutics (2005)
Peer-reviewedGandhi et al., AAPS PharmSciTech (2014)
RegulatoryUK EVM + SACN dose limits observed
Allergen controlAuto-excluded at formula generation

Common questions

About the technology.

Two minutes. One formula. From £79/month · No minimum term

See what your formula looks like.

Build my formulaView ingredients